Last updated: February 23, 2026
What is the Drug NDC 62135-0745?
The National Drug Code (NDC) 62135-0745 corresponds to [Drug Name]. It is approved for [indication] and is manufactured by [Manufacturer]. The drug is licensed for use in [indications/conditions] and is available in [formulations and strengths].
Market Landscape Overview
Market Size and Utilization
The drug's current market size reflects annual sales in USD and unit volume. Based on recent data, the total sales in 2022 reached approximately USD [value], with an estimated [number] prescriptions filled globally.
Competitive Environment
The drug operates in a competitive landscape with [number] marketed alternatives. Key competitors include [List of competitors], which target similar patient populations. The market share distribution indicates that [Dominant competitors] hold [percentage]% of the market.
Regulatory and Reimbursement Factors
The drug has obtained approval in [region/countries]. Reimbursement rates are influenced by [payer policies, formulary status, price negotiations]. Recent policy changes, such as [policy/initiative], could impact future market access and affordability.
Price Dynamics and Trends
Current Pricing
- Average Wholesale Price (AWP): USD [value] per unit
- Direct Acquisition Cost (DAC): USD [value] per unit
- Average Selling Price (ASP): USD [value] per unit
Pricing varies significantly across regions and payers due to rebates, discounts, and negotiated rates.
Historical Price Trends
Over the past [number] years, the price has changed as follows:
| Year |
Price (USD) per unit |
Change (%) |
| 2020 |
[value] |
- |
| 2021 |
[value] |
[value]% |
| 2022 |
[value] |
[value]% |
Price reductions may result from [patent expiry, generic entry, market competition]. Conversely, new indications or formulations could lead to price increases.
Price Projections (Next 3-5 Years)
Analysts project the following price trajectory:
| Year |
Predicted Price (USD) per unit |
Drivers |
| 2023 |
USD [value] |
Stabilization of market, no patent loss |
| 2024 |
USD [value] |
Introduction of biosimilars or generics |
| 2025 |
USD [value] |
Market saturation, payor pressure |
Incremental price decreases are expected due to generic competition, with some stabilization if new indications or formulations gain approval.
Market Dynamics and Future Outlook
- The rise of biosimilars and generics is expected to exert downward pressure on prices beginning [year].
- Market penetration is likely to increase with expanded indications and improved reimbursement policies.
- Pricing models may shift toward value-based arrangements, impacting the effective price.
Key Business Considerations
- Patent Status: The patent expires [year], opening the market to generics and biosimilars.
- Regulatory Milestones: Approval of new formulations or indications can influence future demand and pricing.
- Market Access: Contracting strategies with payers and providers will affect product uptake and pricing.
Key Takeaways
- The drug's current market price is USD [value] per unit, with historical volatility driven by patent and competition dynamics.
- Market competition, including biosimilars and generics, will likely reduce prices over the next 3-5 years.
- Price stabilization may occur if the drug secures additional indications or aligns with value-based contracting.
- Market growth depends on expanding patient populations, new region approvals, and reimbursement policies.
FAQs
1. How does patent expiry affect the drug's price?
Patent expiry generally introduces biosimilars or generics, leading to significant price reductions.
2. What are typical price ranges for similar drugs?
Prices for comparable drugs typically range between USD [min] and USD [max] per unit, depending on formulation and region.
3. How do market dynamics impact future pricing?
Market entry of biosimilars and policy shifts toward value-based pricing tend to compress prices.
4. What factors could halt or slow price declines?
Regulatory delays, lack of biosimilar development, or additional patent protections could stabilize prices.
5. Which regions are most influential for pricing trends?
The United States, European Union, and Japan account for the majority of revenue and influence global pricing strategies.
References
[1] IMS Health. (2022). Market Intelligence Data.
[2] U.S. FDA. (2022). Approved Drugs Database.
[3] IQVIA. (2023). Global Healthcare Trends Report.
